Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy.

@article{Kharlip2009RecurrenceOH,
  title={Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy.},
  author={Julia N Kharlip and Roberto Salvatori and Gayane Yenokyan and Gary Wand},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2009},
  volume={94 7},
  pages={2428-36}
}
CONTEXT Recurrence of hyperprolactinemia after cabergoline withdrawal ranges widely from 36 to 80%. The Pituitary Society recommends withdrawal of cabergoline in selected patients. OBJECTIVE Our aim was to evaluate recurrence of hyperprolactinemia in patients meeting The Pituitary Society guidelines. DESIGN Patients were followed from the date of discontinuation to either relapse of hyperprolactinemia or the day of last prolactin test. SETTING We conducted the study at an academic medical… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 42 extracted citations

Long-term evolution and outcomes of microprolactinoma with medical treatment.

Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion • 2013
View 3 Excerpts
Highly Influenced

Macroprolactinoma: a diagnostic and therapeutic update.

QJM : monthly journal of the Association of Physicians • 2013
View 3 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 15 references

Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline

A Colao, M Galderisi, +7 authors G Lombardi
J Clin Endocrinol Metab • 2008

Similar Papers

Loading similar papers…